BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19109766)

  • 1. A meta-analysis of acupuncture combined with opioid receptor agonists for treatment of opiate-withdrawal symptoms.
    Liu TT; Shi J; Epstein DH; Bao YP; Lu L
    Cell Mol Neurobiol; 2009 Jun; 29(4):449-54. PubMed ID: 19109766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin.
    Liu TT; Shi J; Epstein DH; Bao YP; Lu L
    Cell Mol Neurobiol; 2009 Feb; 29(1):17-25. PubMed ID: 18584321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized effectiveness trial of methadone, TENS and methadone plus TENS in management of opiate withdrawal symptoms.
    Bakhshani NM; Lashkaripour K; Sadjadi SA
    J Pak Med Assoc; 2008 Dec; 58(12):667-71. PubMed ID: 19157318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (3):CD003409. PubMed ID: 12917966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2002; (2):CD003409. PubMed ID: 12076479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Minozzi S; Ferroni E; Ali R; Ferri M
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD003409. PubMed ID: 23450540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2003; (2):CD003409. PubMed ID: 12804464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell MF; Ali R; White JM
    Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auricular acupuncture as an adjunct to opiate detoxification treatment: effects on withdrawal symptoms.
    Bearn J; Swami A; Stewart D; Atnas C; Giotto L; Gossop M
    J Subst Abuse Treat; 2009 Apr; 36(3):345-9. PubMed ID: 19004596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant laser meridian massage in men with opioid use disorder on methadone maintenance treatment: Protocol for a case-controlled study.
    Hu WL; Tsai MC; Kuo CE; Liu CT; Wu SY; Wu TC; Hung YC
    Medicine (Baltimore); 2019 Sep; 98(39):e17319. PubMed ID: 31574863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Minozzi S; Ali R; Ferri M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003409. PubMed ID: 16034898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acupuncture for Opioid Dependence Patients Receiving Methadone Maintenance Treatment: A Network Meta-Analysis.
    Wen H; Chen R; Zhang P; Wei X; Dong Y; Ge S; Luo W; Zhou Y; Xiao S; Lu L
    Front Psychiatry; 2021; 12():767613. PubMed ID: 34966304
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation on the treatment of morphine addiction by acupuncture Chinese herbs and opioid peptides.
    Yang MM; Kwok JS
    Am J Chin Med; 1986; 14(1-2):46-50. PubMed ID: 2870636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture for Detoxification in Treatment of Opioid Addiction.
    Wu SL; Leung AW; Yew DT
    East Asian Arch Psychiatry; 2016 Jun; 26(2):70-6. PubMed ID: 27377488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
    Saulle R; Vecchi S; Gowing L
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002024. PubMed ID: 15495025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
    Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
    Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha2 adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White J
    Cochrane Database Syst Rev; 2003; (2):CD002024. PubMed ID: 12804419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.